Proteomic Services

Proteomic Profiling

The Reverse Phase Protein Microarray (RPMA) is a flexible, high density protein lysate microarray that offers key advantages over alternative proteomic technologies through its sensitivity, sample throughput, data consistency and speed.

Laser Capture Microdissection

Theranostics Health provides pathologist-directed laser capture microdissection (LCM) services to isolate, or enrich for, specific cells of interest (e.g. tumor or stromal cells) from a prepared tissue section.

Preclinical Applications

For investigators engaged in preclinical R&D efforts, Theranostics Health provides services that are applicable to target identification and validation, model system assessment and validation (e.g. cell-based and xenograft models), screening for lead compounds and optimization of compounds in SAR (structure-activity relationship) studies.

Clinical Applications

Our services can help identify, assess and validate target and pathway-specific biomarkers for signs of efficacy in early clinical trials to helping determine which disease indication, cancer population, or subset of patients would better respond to a therapy or combination of therapies.

Custom Services

Theranostics Health provides a range of assay development and validation services that provide investigators with the opportunity to customize our technologies to meet their research requirements.